Identification of molecular signatures associated with sleep disorder and Alzheimer’s disease

Abstract

AD pathology and pathways of neurodegeneration participate in processes contributing in AD and sleep disorder. Hub genes may be worth exploring as potential candidates for targeted therapy of AD and sleep disorder.